Part D Senior Savings Model Now Accepting Pharmaceutical Manufacturer Applications

Part D Senior Savings Model Now Accepting Pharmaceutical Manufacturer Applications Today, the Centers for Medicare and Medicaid Services (CMS) released a Request for Applications (RFA) for eligible pharmaceutical manufacturers interested in participating in the CMS Innovation Center’s Part D Senior Savings (PDSS) Model in 2023. The application deadline for interested manufacturers of Model Drugs who are not currently participating in the PDSS Model is Friday, February 4, 2022. CMS also intends to release an RFA for Part D sponsors that are interested in participating in the Model for CY 2023 and this information will be posted on the Model website when available. Now in its third year, the PDSS Model is designed to provide Medicare beneficiaries with new choices of Part D plans that offer insulin at an affordable and predictable price. By limiting beneficiary cost-sharing, CMS aims to provide equitable access to this critical, life-saving drug. The RFA, along with the latest model announcements, can be found on the Part D Senior Savings Model webpage. Follow us on Twitter | Visit the CMS Innovation Center website

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.